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ficient to allow mitochondrial function during isometric con-
traction, which is the primary period of flow limitation.
Drs Green and Bülow are concerned that the normal postex-
ercise hyperemic response may be blunted in claudicants. As
demonstrated by the end exercise data, postexercise perfusion was
not a limiting factor to mitochondrial function after this mild pro-
tocol since oxygen is not completely depleted at the end of the 90
seconds of plantar flexion. Blood flow is directly reflected to intra-
cellular pH during the recovery period, and in our two groups
intracellular pH was no different at any time point postexercise
(see table above). Specifically, both the Minimum Recovery pH
and the End Recovery pH were no different in the two groups
(see table above). Furthermore, since pH recovery relies on per-
fusion to wash out the H+ ions built up during anaerobic metab-
olism, blood flow was not significantly limited in any of the
claudicants in our study.
Drs Green and Bülow are correct in stating that a direct mea-
surement of blood flow was not obtained. However, we believe
that these data validate our thesis that the specific exercise proto-
col used in patients with mild to moderate claudication (ankle-
brachial index < 0.8 but > 0.5) enables for testing of muscle
bioenergetics under conditions of minimally perturbed blood
flow, which allows for direct study of mitochondrial function
without the confounding effects of ischemia.
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Regarding “High endogenous estradiol is associated
with increased venous distensibility and clinical
evidence of varicose veins in menopausal women”
To the Editors:
In a recently published paper (J Vasc Surg 2000;32:544-9)
are the results of a clinical and instrumental investigation on the
association between estrogen and varicose veins. In fact, the
authors give—for the first time—elegant proof that high endoge-
nous estradiol is associated with clinical evidence of varicose veins.
Based on plethysmographic (SPG) calf volume measure-
ments, the authors go further and state that high endogenous
estradiol is associated also with increased venous distensibility. But
this second statement is not justified in the light of the type of
measurements performed.
The plethysmographic test performed by the authors mea-
sures the change (increase) in calf volume during standard occlu-
sion of the thigh. This change is called venous capacitance or
maximal venous incremental volume (MVIV), but does not repre-
sent “a measure of venous distensibility.”
What MVIV represents is merely the amount (volume) of
blood needed to fill the calf veins, and this volume is certainly
greater if there are also varicose veins to fill. In other words, in
this study higher MVIV and varicose veins are the same thing, and
if one of these is associated with high dose endogenous estradiol,
the other will be, too.
Unfortunately, the inappropriate statement that “high
endogenous estradiol is associated with increased venous distensi-
bility” is the very title of the article and is repeated in the abstract.
Readers are thus misled to believe in “scientific fact” that has been
neither tested nor proved by the authors.
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Reply
Venous distensibility can be measured in several ways. The
most accurate method is to measure changes in volume at differ-
ent values of congesting pressure. However, venous capacitance at
a standard value of congesting pressure does represent a measure
of venous distensibility and has been used in other studies.1,2
Venous filling is a function of venous distensibility: the more
blood the venous bed is able to accept at a determined value of
congesting pressure, the more distensible veins are. In our paper,3
we have clearly stated in the “Methods” section that what we
measured was venous capacitance or maximal incremental venous
volume (MVIV), and also in the tables we use the term MVIV.
Are higher MVIV and varicose veins the same thing, and if
one is associated with a parameter, will the other be, too? In most
Claudicants Controls P value
Resting values
PCr (mmol/L) 27.35 ± 0.37 27.81 ± 0.58 .45
Pi (mmol/L) 3.83 ± 0.15 3.72 ± 0.21 .69
ADP (mol/L) 7.73 ± 0.43 7.62 ± 0.64 .89
Exercise metabolism values
An Gly (mmol/L/s) 0.14 ± 0.01 0.13 ± 0.01 .92
CK (mmol/L/s) 0.07 ± 0.01 0.06 ± 0.01 .60
Ox phos (mmol/L/s) 0.12 ± 0.02 0.13 ± 0.01 .71
pH values
End exercise pH 7.11 ± 0.01 7.11 ± 0.01 .90
Minimum recovery pH 6.96 ± 0.03 6.99 ± 0.02 .47
End recovery pH 7.01 ± 0.04 7.04 ± 0.03 .48
PCr, Phosphocreatine; Pi, inorganic phosphate; ADP, adenosine diphosphate; An Gly, anaerobic glycolysis; CK, creatine kinase pathway; OxPhos, oxida-
tive phosphorylation.
